United Therapeutics | UTHR - Beneficio Operativo

Precio De Mercado
567.16
Cambio Diario
-5.69 -0.99%
Mensual
4.72%
Anual
94.65%
Q2 Expectativa
555.02




Beneficio Operativo Cambio Fecha
Amarin USD -2.26M 564K 2025-12
Ardelyx USD 5.1M 431K 2025-12
Baxter International USD -214.2M 415.4M 2025-12
Bayer EUR 1.11B 1.65B 2025-12
BioCryst Pharmaceuticals USD 260.38M 230.79M 2025-12
Biogen USD 659.6M 192.2M 2025-09
BioMarin Pharmaceutical USD 198.39M 230.08M 2025-12
Emergent BioSolutions USD -218M 69.9M 2023-06
Esperion Therapeutics USD 85.23M 95.19M 2025-12
Gilead Sciences USD 2.96B 551M 2025-12
GlaxoSmithKline GBP 1.44B 1.35B 2025-12
Halozyme Therapeutics USD -88.41M 306.33M 2025-12
Insmed USD -249.71M 11.64M 2025-12
Ionis Pharmaceuticals USD -215M 54.82M 2025-12
J&J USD 6.62B 1.03B 2026-03
Lexicon Pharmaceuticals USD -14.78M 2.59M 2025-12
Moderna USD -857M 597M 2025-12
Omeros USD -35.41M 23.75M 2024-09
Pfizer USD 4.65B 3.99B 2025-12
PTC Therapeutics USD -81.62M 85.11M 2025-12
Regeneron Pharmaceuticals USD 898.6M 211.3M 2025-12
Sangamo BioSciences USD -33.51M 12.77M 2024-06
Sarepta Therapeutics USD -410.08M 347.2M 2025-12
Teva Pharmaceutical Industries USD 487M 581M 2025-12
United Therapeutics USD -14.6M 403.9M 2025-12
Vertex Pharmaceuticals USD 1.26B 24.5M 2025-12